Il trattamento del moncone pancreatico dopo duodenocefalopancreatectomia

Translated title of the contribution: Management of pancreatic stump after pancreatoduodenectomy

V. Di Carlo, A. Zerbi, G. Balzano

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Pancreatojejunal anastomosis still represents the main source of postoperative complications after pancreatoduodenectomy. In this study our experience on the occlusion of the residual pancreatic stump instead of pancreatojejunal anastomosis is reviewed. Between March 1981 and December 1995 we performed 223 pancreatoduodenectomies using Neoprene injection into the Wirsung duct for pancreatic carcinoma of the head (123 cases), ampullary carcinoma (36 cases), distal bile duct cancer (23 cases), islet cells carcinoma (17 cases), chronic pancreatitis (11 cases), duodenal carcinoma (5 cases), miscellaneous diseases (8 cases). Neoprene is a fluid, synthetic glue which polymerized and hardens when in contact with the pancreatic juice, inducing a fibrosis tissue which spares the endocrine component. We observed a 4.9% operative mortality (11 patients): 5 abdominal sepsis, 1 DIC, 1 aortoiliac thrombosis, 1 pulmonary embolism, 1 stroke, 1 hepatic failure, 1 cardiac failure. Overall morbidity was 44.8% (100 patients): in 25 cases (11.2%) a major complication requiring reintervention occurred. In 38 patients (17%) pancreatic fistula was detected: median duration was 43 days, with a mean output of 53 ml/day; in all cases a spontaneous solution of the fistula was observed. In conclusion, intraductal injection of Neoprene after pancreatoduodenectomy is a safe procedure, it represents an useful alternative to pancreatico-jejunal anastomosis.

Original languageItalian
Pages (from-to)617-622
Number of pages6
JournalAnnali Italiani di Chirurgia
Volume68
Issue number5
Publication statusPublished - Sep 1997

Fingerprint

Neoprene
Pancreaticoduodenectomy
Islet Cell Carcinoma
Bile Duct Neoplasms
Pancreatic Fistula
Carcinoma
Pancreatic Juice
Dacarbazine
Injections
Pancreatic Ducts
Liver Failure
Chronic Pancreatitis
Pulmonary Embolism
Adhesives
Fistula
Sepsis
Thrombosis
Fibrosis
Heart Failure
Stroke

ASJC Scopus subject areas

  • Surgery

Cite this

Il trattamento del moncone pancreatico dopo duodenocefalopancreatectomia. / Di Carlo, V.; Zerbi, A.; Balzano, G.

In: Annali Italiani di Chirurgia, Vol. 68, No. 5, 09.1997, p. 617-622.

Research output: Contribution to journalArticle

@article{6588c848433b42d6b2aafd0cc33f66d4,
title = "Il trattamento del moncone pancreatico dopo duodenocefalopancreatectomia",
abstract = "Pancreatojejunal anastomosis still represents the main source of postoperative complications after pancreatoduodenectomy. In this study our experience on the occlusion of the residual pancreatic stump instead of pancreatojejunal anastomosis is reviewed. Between March 1981 and December 1995 we performed 223 pancreatoduodenectomies using Neoprene injection into the Wirsung duct for pancreatic carcinoma of the head (123 cases), ampullary carcinoma (36 cases), distal bile duct cancer (23 cases), islet cells carcinoma (17 cases), chronic pancreatitis (11 cases), duodenal carcinoma (5 cases), miscellaneous diseases (8 cases). Neoprene is a fluid, synthetic glue which polymerized and hardens when in contact with the pancreatic juice, inducing a fibrosis tissue which spares the endocrine component. We observed a 4.9{\%} operative mortality (11 patients): 5 abdominal sepsis, 1 DIC, 1 aortoiliac thrombosis, 1 pulmonary embolism, 1 stroke, 1 hepatic failure, 1 cardiac failure. Overall morbidity was 44.8{\%} (100 patients): in 25 cases (11.2{\%}) a major complication requiring reintervention occurred. In 38 patients (17{\%}) pancreatic fistula was detected: median duration was 43 days, with a mean output of 53 ml/day; in all cases a spontaneous solution of the fistula was observed. In conclusion, intraductal injection of Neoprene after pancreatoduodenectomy is a safe procedure, it represents an useful alternative to pancreatico-jejunal anastomosis.",
keywords = "Pancreatic cancer, Pancreatic fistula, Pancreaticoduodenectomy",
author = "{Di Carlo}, V. and A. Zerbi and G. Balzano",
year = "1997",
month = "9",
language = "Italian",
volume = "68",
pages = "617--622",
journal = "Annali Italiani di Chirurgia",
issn = "0003-469X",
publisher = "Edizioni Luigi Pozzi S.r.l.",
number = "5",

}

TY - JOUR

T1 - Il trattamento del moncone pancreatico dopo duodenocefalopancreatectomia

AU - Di Carlo, V.

AU - Zerbi, A.

AU - Balzano, G.

PY - 1997/9

Y1 - 1997/9

N2 - Pancreatojejunal anastomosis still represents the main source of postoperative complications after pancreatoduodenectomy. In this study our experience on the occlusion of the residual pancreatic stump instead of pancreatojejunal anastomosis is reviewed. Between March 1981 and December 1995 we performed 223 pancreatoduodenectomies using Neoprene injection into the Wirsung duct for pancreatic carcinoma of the head (123 cases), ampullary carcinoma (36 cases), distal bile duct cancer (23 cases), islet cells carcinoma (17 cases), chronic pancreatitis (11 cases), duodenal carcinoma (5 cases), miscellaneous diseases (8 cases). Neoprene is a fluid, synthetic glue which polymerized and hardens when in contact with the pancreatic juice, inducing a fibrosis tissue which spares the endocrine component. We observed a 4.9% operative mortality (11 patients): 5 abdominal sepsis, 1 DIC, 1 aortoiliac thrombosis, 1 pulmonary embolism, 1 stroke, 1 hepatic failure, 1 cardiac failure. Overall morbidity was 44.8% (100 patients): in 25 cases (11.2%) a major complication requiring reintervention occurred. In 38 patients (17%) pancreatic fistula was detected: median duration was 43 days, with a mean output of 53 ml/day; in all cases a spontaneous solution of the fistula was observed. In conclusion, intraductal injection of Neoprene after pancreatoduodenectomy is a safe procedure, it represents an useful alternative to pancreatico-jejunal anastomosis.

AB - Pancreatojejunal anastomosis still represents the main source of postoperative complications after pancreatoduodenectomy. In this study our experience on the occlusion of the residual pancreatic stump instead of pancreatojejunal anastomosis is reviewed. Between March 1981 and December 1995 we performed 223 pancreatoduodenectomies using Neoprene injection into the Wirsung duct for pancreatic carcinoma of the head (123 cases), ampullary carcinoma (36 cases), distal bile duct cancer (23 cases), islet cells carcinoma (17 cases), chronic pancreatitis (11 cases), duodenal carcinoma (5 cases), miscellaneous diseases (8 cases). Neoprene is a fluid, synthetic glue which polymerized and hardens when in contact with the pancreatic juice, inducing a fibrosis tissue which spares the endocrine component. We observed a 4.9% operative mortality (11 patients): 5 abdominal sepsis, 1 DIC, 1 aortoiliac thrombosis, 1 pulmonary embolism, 1 stroke, 1 hepatic failure, 1 cardiac failure. Overall morbidity was 44.8% (100 patients): in 25 cases (11.2%) a major complication requiring reintervention occurred. In 38 patients (17%) pancreatic fistula was detected: median duration was 43 days, with a mean output of 53 ml/day; in all cases a spontaneous solution of the fistula was observed. In conclusion, intraductal injection of Neoprene after pancreatoduodenectomy is a safe procedure, it represents an useful alternative to pancreatico-jejunal anastomosis.

KW - Pancreatic cancer

KW - Pancreatic fistula

KW - Pancreaticoduodenectomy

UR - http://www.scopus.com/inward/record.url?scp=0031219389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031219389&partnerID=8YFLogxK

M3 - Articolo

VL - 68

SP - 617

EP - 622

JO - Annali Italiani di Chirurgia

JF - Annali Italiani di Chirurgia

SN - 0003-469X

IS - 5

ER -